Loading...

Chinese embrace online healthcare

Image

19-Jul-16 Chinese people, now becoming increasingly tech-savvy, are embracing Internet-based medical care, according to a recent survey by Accenture. 70% had opted for online medical services via a mobile app or WeChat. 75% had searched for medication and information on medication online. Up to 60% said they had used “online doctor” consulting services. [image: Long Wei / China Daily]

Read More

China is catching up fast in medicine

Image

10-Jul-16 In a medical power shift in Asia, China is catching up fast with Korea and even Japan. Although it is still unclear how much money China spends on medical R&D, the country now makes up 20% of the world's total R&D expenditures, second only after the US (27%), according to the 2016 Science & Engineering Indicators report. [image: Korea Times / Jung Min-ho]

Read More

China may end India's drug trade dominance

Image

05-Jul-16 India is making steady progress in the export of drugs around the world. India's Commerce & Industry Ministry said "India's pharmaceutical exports continued their lead over China in 2015." However, experts warn this trend will wane if Indian firms continue to depend on Chinese raw materials. [image: Pixabay]

Read More

China healthcare costs forcing patients into crippling debt

Image

09-Jul-16 As China's medical bills rise steeply, outpacing government insurance provision, patients and their families are increasingly turning to loans to pay for healthcare, adding to the country's growing burden of consumer debt. That is luring big companies like Ping An Insurance as well as small loan firms and P2P platforms, as China's traditional savings culture proves inadequate. [image: Reuters / David Gray]

Read More

Report outlines reforms for China's pharmaceutical system

Image

07-Jul-16 China’s pharmaceutical system will struggle to cope with a rapidly aging population and increases in non-communicable diseases says a report by LSE Health and the State Council. The report identifies market fragmentation as a major challenge, with the top five manufacturers holding <15% market share, and finds R&D accounts for only 2% of sales, compared with 14-18% for MNC pharma companies. [image: LSE]

Read More